United States Botulinum Toxins Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)
Table of Contents
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 18.104.22.168. Secondary Instrument
- 22.214.171.124. Primary Instrument
- 2.1.2. Research Approaches
- 126.96.36.199. Bottom-up Approach
- 188.8.131.52. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.2. Restraints
- 4.4.3. Opportunities
- 4.4.4. Challenges
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Threat of New Entrants
- 4.5.2. Threat of Substitutes
- 4.5.3. Bargaining Power of Customers
- 4.5.4. Bargaining Power of Suppliers
- 4.5.5. Industry Rivalry
- 4.6. Botox usage Dermatology Partners in U.S.
- 4.7. Regulation of Cosmetic Interventions in U.S.
5. United States Botulinum Toxins Market, by Type
- 5.1. Introduction
- 5.2. AbobotulinumtoxinA
- 5.3. IncobotulinumtoxinA
- 5.4. OnabotulinumtoxinA
- 5.5. RimabotulinumtoxinB
6. United States Botulinum Toxins Market, by Application
- 6.1. Introduction
- 6.2. Aesthetic
- 6.3. Therapeutic
7. 360iResearch Competitive Strategic Window
- 7.1. Introduction
- 7.1.1. Leverage Zone
- 7.1.2. Vantage Zone
- 7.1.3. Speculative Zone
- 7.1.4. Bottleneck Zone
8. 360iResearch FPNV Positioning Matrix
- 8.1. Introduction
- 8.2. 360iResearch Scores
- 8.2.1. Forefront
- 8.2.2. Pathfinders
- 8.2.3. Niche
- 8.2.4. Vital
- 8.3. Business Strategy
- 8.4. Product Satisfaction
9. Competitive News Feed Analysis
10. Company Usability Profiles
- 10.1. Allergan Inc.
- 10.2. Galderma S.A.
- 10.3. Ipsen group
- 10.4. Lanzhou Institute of Biological Products Co. Ltd.
- 10.5. Medytox Inc.
- 10.6. Merz GmbH and Co. KGaA
- 10.7. Pfizer Inc.
- 10.8. Revance Therapeutics, Inc.
- 10.9. US Worldmed, LLC
- 10.10. Valeant Pharmaceuticals
- 10.11. Zeltiq Aesthetics
- 11.1. Top Reports
- 11.2. Author Details
LIST OF TABLES (10 TABLES)
TABLE 1. UNITED STATES BOTULINUM TOXINS MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. UNITED STATES BOTULINUM TOXINS MARKET RANKING, BY VENDORS, 2017
TABLE 3. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 4. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 5. 360IRESEARCH SCORES FOR FOREFRONT IN BOTULINUM TOXINS MARKET
TABLE 6. 360IRESEARCH SCORES FOR PATHFINDERS IN BOTULINUM TOXINS MARKET
TABLE 7. 360IRESEARCH SCORES FOR NICHE IN BOTULINUM TOXINS MARKET
TABLE 8. 360IRESEARCH SCORES FOR VITAL IN BOTULINUM TOXINS MARKET
TABLE 9. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR BOTULINUM TOXINS MARKET
TABLE 10. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR BOTULINUM TOXINS MARKET
LIST OF FIGURES (16 TABLES)
FIGURE 1. UNITED STATES BOTULINUM TOXINS MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. UNITED STATES BOTULINUM TOXINS MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. UNITED STATES BOTULINUM TOXINS MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. UNITED STATES BOTULINUM TOXINS MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. UNITED STATES BOTULINUM TOXINS MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. UNITED STATES BOTULINUM TOXINS MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. UNITED STATES BOTULINUM TOXINS MARKET: KEY RESEARCH APPROACHES
FIGURE 8. UNITED STATES BOTULINUM TOXINS MARKET: KEY DATA TRIANGULATION
FIGURE 9. UNITED STATES BOTULINUM TOXINS MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. BOTULINUM TOXINS MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. UNITED STATES BOTULINUM TOXINS MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)
FIGURE 13. UNITED STATES BOTULINUM TOXINS MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 14. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BOTULINUM TOXINS MARKET, BY TYPE, 2024
FIGURE 15. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES BOTULINUM TOXINS MARKET, BY APPLICATION, 2024
FIGURE 16. 360IRESEARCH FPNV POSITIONING MATRIX FOR BOTULINUM TOXINS MARKET
The united states botulinum toxins market is expected to grow from USD 942.46 million 2017 to USD 1,598.76 million by the end of 2024, at a Compound Annual Growth Rate (CAGR) of 7.84%.
Market Segmentation & Coverage: The report on united states botulinum toxins market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the economies and geographies of the potential customer group can help to gain business acumen for better strategic decision making. Our market coverage across different industry verticals reveals the hidden truth about the strategies adopted by the players in different verticals and help the organization to decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.This research report categorizes the united states botulinum toxins market to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type
Based on Application
Company Usability Profiles:
The botulinum toxins market research report provides the company usability profiles and analyze the business overview, business product offering, SWOT analysis, and business strategy of the following company:
1. Allergan Inc.
2. Galderma S.A.
3. Ipsen group
4. Lanzhou Institute of Biological Products Co. Ltd.
5. Medytox Inc.
6. Merz GmbH and Co. KGaA
7. Pfizer Inc.
8. Revance Therapeutics, Inc.
9. US Worldmed, LLC
10. Valeant Pharmaceuticals
11. Zeltiq Aesthetics
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
Reasons to Buy:
1. To comprehensively understand of the botulinum toxins market with respect to major influencing factor such as drivers, restraints, opportunities and challenges
2. To strategically analyze each vertical and geographic sub-segment in the botulinum toxins market and its individual growth and its impact towards the growth of overall market
3. To position selected vendors in 360iResearch FPNV Positioning Matrix for the botulinum toxins market to uncover a competitive landscape based on business strategy and product satisfaction